List Of Penny Stocks To Watch Making Bigger Moves Right now
While some may avoid penny stocks because they don’t understand risk, others jump headfirst. But why? For the most part, someone trading penny stocks enjoys volatility. With that comes greater levels of riskiness. Where you could buy one share of Facebook for around $200, you could pick up 10,000 shares of a $0.02 stock.
You’re probably thinking, “That’s how math works” and you’d be correct. But while it takes Facebook $200 to return 100% on your investment, the penny stock only needs to move a few pennies. Given the fact that it took 6 years to rise $200 per share, the penny stock could present a much more near-term opportunity to double that initial investment.
On the flip side, Facebook isn’t likely to drop $200 a share in the near term. In this case, you wouldn’t likely see your entire investment dissolve into thin air. With the penny stock, a drop of even one cent means you lost half your capital.
This is where your risk profile is important. Most traders will only risk what they can comfortably afford to lose. If that is $100 or $100,000, it’s completely based on each person’s individual financial state. With this said, if you’re still interested in penny stocks, and have a good understanding of the basics, we’ve got a list of penny stocks to watch right now. These have started making bigger moves at the end of the month. But are they going to be the best to watch before the beginning of March?
Penny Stocks To Trade [or ignore]: ADDvantage Technologies
One of the penny stocks to watch for the last year has been ADDvantge Technologies (AEY – Free Report). We first reported on it last May in the article “5 Penny Stocks To Watch That Just Made New Highs This Month“. Since then, ADDvantage stock has jumped nearly 290%. While we’ve tracked the progress along the way, this year has been even bigger for AEY stock. The company distributes and services a line of electronics and hardware for cable and telecom.
Most recently the company saw a transition in its CFO position. This came after the company reported strong earnings for its first quarter of fiscal 2020. Joe Hart, President and CEO stated in a press release, “The steps taken in the second half of 2019 to prepare the company for future growth are beginning to yield results as we have a robust pipeline of opportunities and continue to see a significant market opportunity with 5G across all of ADDvantage’s businesses.”
Read More
- Best Penny Stocks To Watch This Week? 1 Up Over 100% This Month
- Short List Of Penny Stocks To Watch Right Now
- Can You Make Money With Penny Stocks? 5 To Watch
Obviously the 5G topic is one of the hottest in tech right now. After the T-Mobile and Sprint merger was confirmed, the conversation began to heat up once again. The company reported a 105% increase in revenue for Q1 of its fiscal 2020. This was greatly aided by its acquisition of Fulton Technologies to create our Wireless Segment last year.
Penny Stocks To Trade [or ignore]: Document Security Systems
Next is a penny stock that was beaten up for quite some time. But Document Security Systems (DSS – Free Report) has started to show some signs of life over the last few days. The penny stock dipped to new 52-week lows on February 21. This came after pricing a $4 million offering at $0.18. Considering the penny stock traded around $0.25 at the time, the near 30% discount didn’t present itself well to the public.
However, since the dust had settled, shares started to climb and with record share volume. Since hitting $0.167 on Friday, DSS stock has recovered by as much as 31%. In light of the raise, there could be a viable use of proceeds to keep in mind down the road. The company plans to use the $4 million proceeds to fund the development of new business lines and to upgrade machinery and facilities.
Document Security Systems focuses on anti-counterfeit, authentication, and brand protection solutions. Its AuthentiGuard(R) is the company’s flagship product and provides authentication capability. This is done through a smartphone application so businesses can empower a wide range of personnel to track their brands and verify authenticity.
Penny Stocks To Trade [or ignore]: Lipocine Inc.
One of the penny stocks that felt the burn last year was Lipocine Inc. (LPCN – Free Report). The company enjoyed a great rally to highs of over $3.40 until it reported really bad news. How bad? Well, when it comes to biotechs with lead treatments missing the mark, it was bad. Its TLANDO treatment is an oral testosterone product candidate for testosterone replacement therapy. It didn’t meet the 3 secondary endpoints for maximal testosterone concentrations.
But you could say there’s a chance after this month. For those looking for beaten-down penny stocks, LPCN might fit the mold. This week, however, the company started off reported that it received some insight from the FDA. The agency indicated Lipocine’s approach to addressing the single remaining deficiency through the reanalysis of existing data in accordance with FDA feedback appears to be a reasonable path forward. The FDA requested that the information generated by the reanalysis be submitted as part of an NDA resubmission with a six-month Prescription Drug User Fee Act clock.
[Read More] Penny Stocks On Robinhood To Buy For Under $2
Long story, short is that Lipocine aims for this quarter to submit the TLANDO NDA. Given this event, the market appears to have reacted favorably. The pressure’s on now, though because after the flop from November, there could be even more weight riding on the next round of results.
Penny Stocks To Trade [or ignore]: Vaxart Inc.
Vaxart Inc. (VXRT – Free Report) caught som wind on Monday kickstarting the week. Shares of the company jumped to highs of $1.35 during premarket trading. But something you’ll see when you pull up this symbol is that there hasn’t been much news. Also, if you’re new to PennyStocks.com, you probably haven’t read any of our past articles on the company.
As discussed in one of the other posts on the site today, Vaxart could be moving in sympathy with other coronavirus penny stocks today. In late January the company announced the initiation of a coronavirus vaccine program. Sean Tucker, Ph.D., chief scientific officer of Vaxart. “The results of our recently published influenza challenge study demonstrated that our oral tablet vaccine primarily protects through mucosal immunity, a potential key factor when targeting mucosal pathogens such as this new coronavirus.”
With the latest surge in new COVID-19 cases, it makes sense that penny stocks like this are moving today. There haven’t been any new updates on progress of the program, however. So it will be interesting to see how things pan out for Vaxart along the way. In any case, it’s one. of the few coronavirus penny stocks that have some new updates related to coronavirus. Other sympathy stocks haven’t had anything but speculation based on information from corporate websites.
Penny Stocks To Trade [or ignore]: Allied Healthcare Products, Inc.
Finally, Allied Healthcare Products, Inc. (AHPI – Free Report) rounds out this list of penny stocks. If this one seems kind of familiar, that’s because we started looking at this one earlier in February. Similar to Vaxart, Allied has benefited from the latest surge in coronavirus cases.
While we’re happy to see AHPI stock has continued higher since we began discussing it, there are some things to take note of. The company sells respiratory products and other healthcare items. Beyond its relation to treating symptoms of the virus, AHPI hasn’t released any news. So while this momentum appears strong, it could be a direct result of COVID-19 speculation.
Remember in the case of Vaxart, it came out and specifically reported its intentions related to the virus. Allied has not. So keep this in mind if AHPI is on your list of penny stocks to watch this week.
